EPIGENETIC THERAPY OF HEMATOPOIETIC MALIGNANCIES: NOVEL APPROACHES FOR TISSUE-SPECIFIC AND GLOBAL INHIBITION OF EZH2 ENZYMATIC ACTIVITIES
$534,407FY2014Department of DefenseDOD
University Of North Carolina At Chapel Hill, Chapel Hill NC
University Of North Carolina At Chapel Hill, Chapel Hill NC